606 related articles for article (PubMed ID: 19190009)
1. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
Doyle B; Al-Mudhaffer M; Kennedy MM; O'Doherty A; Flanagan F; McDermott EW; Kerin MJ; Hill AD; Quinn CM
J Clin Pathol; 2009 Jun; 62(6):534-8. PubMed ID: 19190009
[TBL] [Abstract][Full Text] [Related]
2. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
3. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
4. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
5. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
6. Management of in situ lobular neoplasia detected on needle core biopsy of breast.
Purdie CA; McLean D; Stormonth E; Macaskill EJ; McCullough JB; Edwards SL; Brown DC; Jordan LB
J Clin Pathol; 2010 Nov; 63(11):987-93. PubMed ID: 20972243
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
[TBL] [Abstract][Full Text] [Related]
8. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
10. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
[TBL] [Abstract][Full Text] [Related]
11. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Intra M; Rotmensz N; Veronesi P; Colleoni M; Iodice S; Paganelli G; Viale G; Veronesi U
Ann Surg; 2008 Feb; 247(2):315-9. PubMed ID: 18216539
[TBL] [Abstract][Full Text] [Related]
13. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Kurniawan ED; Rose A; Mou A; Buchanan M; Collins JP; Wong MH; Miller JA; Mann GB
Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099
[TBL] [Abstract][Full Text] [Related]
15. Point: sentinel lymph node biopsy is indicated for patients with DCIS.
Cody HS; Van Zee KJ
J Natl Compr Canc Netw; 2003 Apr; 1(2):199-206. PubMed ID: 19768878
[TBL] [Abstract][Full Text] [Related]
16. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
18. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
Catteau X; Simon P; Noël JC
Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
[TBL] [Abstract][Full Text] [Related]
19. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
20. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]